Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia research 2010-01, Vol.34 (1), p.e5-e7
Hauptverfasser:	Mariani, Stefania, Tornaghi, Lucia, Sassone, Marianna, Basciani, Sabrina, Buzzetti, Raffaella, Gambacorti-Passerini, Carlo, Spera, Giovanni, Gnessi, Lucio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - therapeutic use Benzamides Blood Glucose - analysis Case-Control Studies Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Female Glucose Tolerance Test Hematology, Oncology and Palliative Medicine Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Middle Aged Piperazines - therapeutic use Pyrimidines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!